Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

Rockstroh, JK; Lacombe, K; Viani, RM; Orkin, C; Wyles, D; Luetkemeyer, AF; Soto-Malave, R; Flisiak, R; Bhagani, S; Sherman, KE; Shimonova, T; Ruane, P; Sasadeusz, J; Slim, J; Zhang, Z; Samanta, S; Ng, TI; Gulati, A; Kosloski, MP; Shulman, NS; Trinh, R; Sulkowski, M

Download

Published version (250.2Kb)

Citations

Web of Science

Altmetric

Author

Rockstroh, JK; Lacombe, K; Viani, RM; Orkin, C; Wyles, D; Luetkemeyer, AF; Soto-Malave, R; Flisiak, R; Bhagani, S; Sherman, KE; ...

Date

2018-10-01

Source Title

Clinical Infectious Diseases

Publisher

OXFORD UNIV PRESS INC

University of Melbourne Author/s

Sasadeusz, Joseph

Affiliation

Doherty Institute

Metadata

Show full item record

Document Type

Abstract

Citations

Rockstroh, J. K., Lacombe, K., Viani, R. M., Orkin, C., Wyles, D., Luetkemeyer, A. F., Soto-Malave, R., Flisiak, R., Bhagani, S., Sherman, K. E., Shimonova, T., Ruane, P., Sasadeusz, J., Slim, J., Zhang, Z., Samanta, S., Ng, T. I., Gulati, A., Kosloski, M. P. ,... Sulkowski, M. (2018). Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. [Abstract]. CLINICAL INFECTIOUS DISEASES, 67 (7), pp.1010-1017. https://doi.org/10.1093/cid/ciy220.

Access Status

Open Access